Depression and Whole Blood Serotonin in Patients With Coronary Heart Disease From the Heart and Soul Study
- 1 April 2009
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 71 (3) , 260-265
Abstract
Objective: To evaluate whether depression is associated with whole blood serotonin in outpatients with stable coronary heart disease (CHD). Depression is associated with incident CHD and with adverse cardiovascular outcomes. Dysregulation of peripheral serotonin, common to both depression and CHD, may contribute to this association. Methods: We performed a cross-sectional study of 791 participants with stable CHD enrolled in the Heart and Soul Study and not taking antidepressant medication. We assessed major depression using the Computerized Diagnostic Interview Schedule (CDIS-IV) and measured whole blood serotonin (WBS) from fasting venous samples. Results: Of the 791 participants, 114 (14%) had current (past month) major depression, 186 (24%) had past (but not current) major depression, and 491 (62%) had no history of depression. Age-adjusted mean WBS was higher in participants with current major depression (139 ± 6.5 ng/ml) than in those with past depression (120 ± 5.0 ng/ml) or no history of depression (119 ± 3.1 ng/ml) (p = .02). This association was unchanged after adjustment for demographic characteristics, medical comorbidities, medication use, and cardiac disease severity (p = .02). When serotonin was analyzed as a dichotomous variable, current depression was associated with a 70% greater odds of having WBS in the highest quartile (adjusted odds ratio = 1.71; 95% Confidence Interval = 1.03–2.83; p = .04). Conclusions: In this sample of patients with stable CHD, current major depression was independently associated with higher mean WBS levels. Future studies should examine whether elevated WBS may contribute to adverse outcomes in patients with depression and CHD. CHD = coronary heart disease; CDIS = computerized diagnostic interview schedule; HPLC = high pressure liquid chromatography; LVEF = left ventricular ejection fraction; MI = myocardial infarction; WBS = whole blood serotonin; 5-HT1 = 5-hydroxytryptophan 1; 5-HT2 = 5-hydroxytryptophan 2.Keywords
This publication has 36 references indexed in Scilit:
- The PHQ-9Journal of General Internal Medicine, 2001
- Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal agingBrain Research Reviews, 1999
- Relationship between serotonergic measures in periphery and the brain of mouseLife Sciences, 1992
- Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlationsJournal of Affective Disorders, 1992
- Clinical Use of the Determination of Serotonin in Whole BloodJournal of Clinical Psychopharmacology, 1990
- Whole blood serotonin and plasma tryptophan using high-pressure liquid chromatography with electrochemical detectionBiochemical Medicine and Metabolic Biology, 1987
- 5‐Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholismActa Psychiatrica Scandinavica, 1978
- Reduction of Blood Platelet Serotonin Levels in Manic and Depressed PatientsPsychiatry and Clinical Neurosciences, 1976
- 5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illnessPostgraduate Medical Journal, 1976
- THE LEVEL AND DIURNAL RHYTHM OF SERUM SEROTONIN IN MANIC-DEPPESSIVE PATIENTSPsychiatry and Clinical Neurosciences, 1968